Michael Hindle, Ph.D.LinkedIn profile for Michael Hindle
Chair of Pharmaceutics and Peter R. Byron Distinguished Professor
Department of Pharmaceutics
Dean's Office
Mike Hindle is the Peter R. Byron Distinguished Professor and chair in the Department of Pharmaceutics at Virginia Commonwealth University. He has a pharmacy degree and a Ph.D. in pharmaceutical technology, both from the University of Bradford, UK.
He has published more than 140 papers, one book chapter and served as co-editor of five books. He has received funding from National Institutes of Health, the Food and Drug Administration and the Bill and Melinda Gates Foundation together with the pharmaceutical industry. He serves on the editorial board of the Journal of Aerosol Medicine and Pulmonary Drug Delivery and the AAPS PharmSciTech Journal. He is a member of the NIH Drug and Biologic Therapeutic Delivery study section and has served on more than 30 NIH review panels.
He holds 10 U.S. patents and five E.U. patents and was inducted as a Fellow of National Academy of Inventors in 2023. Hindle is co-inventor of technologies that seek to significantly improve pharmaceutical aerosol delivery to the lungs and his research is particularly focused on challenging patient populations such as infants, in which he combines in silico computational fluid dynamics with in vitro characterization studies. His group is currently developing a dry powder lung surfactant formulation to treat premature infants and adults with respiratory distress syndrome.